Search research articles
Contact Us
Filters
Showing results (51-60 of 220) with videos related to
Page
of 22
Sort By:
The Journal of Antimicrobial Chemotherapy
|
December 24, 2011
Pharmacogenetics of hepatitis C
Vincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Expert Opinion on Drug Safety
|
June 5, 2013
Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management
Jose V Fernandez-Montero, Eugenia Eugenia, Pablo Barreiro, et al.
Infectious Disease Clinics of North America
|
October 23, 2012
Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era
Vincent Soriano, Pablo Labarga, Eugenia Vispo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2012
Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver
Pablo Barreiro, Eugenia Vispo, Eva Poveda, et al.
AIDS (London, England)
|
June 7, 2013
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients
Eugenia Vispo, José Vicente Fernández-Montero, Pablo Labarga, et al.
Current HIV/AIDS Reports
|
July 9, 2013
Update on HIV/HCV coinfection
Vincent Soriano, Eugenia Vispo, Jose Vicente Fernandez-Montero, et al.
AIDS Reviews
|
March 23, 2023
Viral hepatitis in persons living with HIV in the post-COVID era
Vicente Soriano, Víctor Moreno-Torres, Carmen de Mendoza, et al.
AIDS Reviews
|
May 16, 2020
COVID-19 Comes 40 Years After AIDS - Any Lesson?
Vicente Soriano, Pablo Barreiro, José Manuel Ramos, et al.
Expert Opinion on Pharmacotherapy
|
April 24, 2014
Dolutegravir, abacavir and lamivudine as HIV therapy
Jose Vicente Fernandez-Montero, Pablo Barreiro, Pablo Labarga, et al.
Journal of Clinical Microbiology
|
February 10, 2004
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations
Carmen de Mendoza, Ellen Paxinos, Pablo Barreiro, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 220) with videos related to
Sort By:
Page
of 22
The Journal of Antimicrobial Chemotherapy
|
December 24, 2011
Pharmacogenetics of hepatitis C
Vincent Soriano, Eva Poveda, Eugenia Vispo, et al.
Expert Opinion on Drug Safety
|
June 5, 2013
Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management
Jose V Fernandez-Montero, Eugenia Eugenia, Pablo Barreiro, et al.
Infectious Disease Clinics of North America
|
October 23, 2012
Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era
Vincent Soriano, Pablo Labarga, Eugenia Vispo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2012
Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver
Pablo Barreiro, Eugenia Vispo, Eva Poveda, et al.
AIDS (London, England)
|
June 7, 2013
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients
Eugenia Vispo, José Vicente Fernández-Montero, Pablo Labarga, et al.
Current HIV/AIDS Reports
|
July 9, 2013
Update on HIV/HCV coinfection
Vincent Soriano, Eugenia Vispo, Jose Vicente Fernandez-Montero, et al.
AIDS Reviews
|
March 23, 2023
Viral hepatitis in persons living with HIV in the post-COVID era
Vicente Soriano, Víctor Moreno-Torres, Carmen de Mendoza, et al.
AIDS Reviews
|
May 16, 2020
COVID-19 Comes 40 Years After AIDS - Any Lesson?
Vicente Soriano, Pablo Barreiro, José Manuel Ramos, et al.
Expert Opinion on Pharmacotherapy
|
April 24, 2014
Dolutegravir, abacavir and lamivudine as HIV therapy
Jose Vicente Fernandez-Montero, Pablo Barreiro, Pablo Labarga, et al.
Journal of Clinical Microbiology
|
February 10, 2004
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations
Carmen de Mendoza, Ellen Paxinos, Pablo Barreiro, et al.
Page
of 22